Abstract During development, the gastrointestinal (GI) tract arises from a primary tube composed of mesoderm and endoderm. The mesoderm gives rise to the digestive mesenchyme, which in turn differentiates into multiple tissues, namely the submucosa, the interstitial cells of Cajal and the smooth muscle cells (SMCs). Concomitant with these early patterning events, the primitive GI tract is colonized by vagal enteric neural crestderived cells (vENCDCs), a population of cells that gives rise to the enteric nervous system, the intrinsic innervation of the GI tract. Reciprocal neuro-mesenchymal interactions are essential for the coordinated development of GI musculature. The aim of this study is to examine and compare the kinetics of mesenchymal cell differentiation into SMCs along the anterior-posterior axis to the pattern of vENCDCs migration using whole-mount in situ hybridization and paraffin section immunofluorescence analyses on chick embryonic GI tracts from E4-Stage 23 to E7-Stages 30-31. We confirmed that gastric and pre-umbilical intestine mesenchyme differentiation into SMCs occurs after vENCDCs colonization. However, we found that colonic and post-umbilical intestine mesenchyme differentiation occurs before vENCDCs colonization. These findings suggest that regional-specific mechanisms are involved in the mesenchyme differentiation into SMCs along the GI anterior-posterior axis.
Introduction
The gastrointestinal (GI) tract is a vital organ essential for the absorption of water and nutrients. The GI tract is formed as a closed primitive tube from the association of the endoderm with the splanchnic mesenchyme at the early embryonic period. The primitive gut tube then becomes regionalized along the anterior-posterior (AP) axis into various organs such as the esophagus, stomach (proventriculus and gizzard in the chicken), duodenum and the intestines (small intestine and colon) and specialized along the radial axis into concentric layers of morphological and functionally distinct cell types (Roberts 2000) . The endoderm gives rise to the mucosa lining the entire gut lumen and the mesenchyme differentiates mainly into circular and longitudinal smooth muscle layers that control gut contractions . These processes of differentiation, according to different axes that are established during development, are essential for the digestive tract to ensure its basic function, namely food digestion, absorption of nutrients and water and elimination of feces Faure and de Santa Barbara 2011) .
Smooth muscle cells (SMCs) have a mesoderm origin (Gabella 2002) . The mesoderm gives rise to the digestive mesenchyme, which in turn differentiates into multiple tissues, such as the submucosa and the musculature, which is composed of SMCs and interstitial cells of Cajal (ICCs) (Wallace and Burns Electronic supplementary material The online version of this article (doi:10.1007/s00441-017-2577-0) contains supplementary material, which is available to authorized users. 2005; Le Guen et al. 2015) . Mesenchyme development into SMCs commonly occurs through two major steps (Gabella 2002) . Mesenchymal progenitor cells first enter a determination program (which we will refer to as SMC determination), mainly characterized by the early expression of alpha smooth muscle actin (αSMA) and SM22 (Faure et al. 2013; McKey et al. 2016) . Later during development, determined SMCs enter a more differentiated state (which we will refer to as SMC differentiation), mainly characterized by the expression of proteins involved in smooth muscle contractility, such as CALPONIN and CALDESMON (McKey et al. 2016) .
Concomitant with these early patterning events, the primitive GI tract is colonized by neural crest precursors, a population of cells that gives rise to the enteric nervous system (ENS), the intrinsic innervation of the GI tract. In chick, the ENS is predominantly derived from vagal enteric neural crestderived cells (vENCDCs) that migrate from the neural tube adjacent to somites 1-7 (Yntema and Hammond 1954; Le Douarin and Teillet 1973; Fairman et al. 1995; Burns and Le Douarin 1998; Burns et al. 2000) . These cells exit the neural tube, enter the esophageal mesenchyme and begin an AP wave of migration through their interaction with mesenchymal extracellular matrix proteins (Burns and Le Douarin 1998; Breau et al. 2006 ). This allows vENCDCs to populate the entire GI tract, from the esophagus to the terminal colon. As the vENCDCs migrate along the GI tract, they proliferate and finally differentiate into neurons and glial cells of the ENS and form two concentric plexuses of ganglion cells localized in muscle layers of the GI wall (Heanue et al. 2016 ). In addition, sacral enteric neural crest cells (sENCCs), which originate from the caudal neural tube, first form the ganglion of Remak and then contribute to neurons and glia to the colorectum and post-umbilical intestine (Pomeranz and Gershon 1990; Burns and Le Douarin 1998) .
While a number of studies have led to the identification of some of the molecular mechanisms that control differentiation of the mesenchyme into smooth muscle in the stomach (Sukegawa et al. 2000; Kim et al. 2005; Le Guen et al. 2009; Notarnicola et al. 2012; Jayewickreme and Shivdasani 2015; Sagnol et al. 2016; McKey et al. 2016) , the examination of when mesenchyme differentiation occurs along the AP axis during GI development has not so far been reported. It has been suggested that GI mesenchyme differentiation into SMCs follows vENCDCs colonization. According to this, gut mesenchyme could mature in an AP direction (Fu et al. 2004; Wallace and Burns 2005; Olden et al. 2008) . We examined the kinetics of mesenchyme differentiation and vENCDCs migration in detail using the chick embryo as a model. We previously reported that stomach mesenchyme determination is initiated after its colonization by vENCDCs . In this study, we focused on the posterior part of the gut. Our data show that the determination and differentiation of the mesenchyme in the post-umbilical intestine and colon is initiated before they are colonized by the vENCDCs.
Materials and methods

Animals
Timed fertilized white Leghorn eggs (Haas Farm, France) were incubated at 38°C in a humidified incubator (Coudelou, France) until used experimentally. Embryos were staged according to Hamburger and Hamilton (1951) by embryonic day (E) for GI tract analysis. Dissected GI tissues were fixed in 4% paraformaldehyde for 1 h at room temperature, washed in PBS, gradually dehydrated in methanol in order to store the samples at −20°C before processing for whole-mount in situ hybridization as described below.
Whole-mount in situ hybridization
Whole-mount in situ hybridization analyses were carried out as described using antisense SOX10 (Moniot et al. 2004 ) and SM22 riboprobes (Faure et al. 2013) . Tissues were gradually rehydrated in PBS, washed in PBT (PBS, 0.1% Tween) and incubated for 1 h in 6% hydrogen peroxide (Sigma, France). Samples were next permeabilized by treatment with proteinase K (10 μg/ml) for 10 min, washed with glycine in PBT and fixed in 4% paraformaldehyde/0.2% gluteraldehyde in PBT for 20 min. Tissues were then hybridized with antisense SOX10 or SM22 digoxigenin-labeled (Roche) riboprobes overnight at 70°C. After post-hybridization washes at 70°C, tissues were incubated in 10% sheep serum for 2.5 h at room temperature and finally mixed with preabsorded antidigoxigenin coupled with alkaline phosphatase antibody (Roche) overnight at 4°C. The complexes were detected with BM Purple, a chromogenic substrate for alkaline phosphatase (Roche).
Immunofluorescence on paraffin sections
For sectioning, tissues were first gradually dehydrated in ethanol, incubated in HistoClear solution (VWR, France) and finally embedded in paraffin. Samples were sectioned at 10 μm using a microtome and collected on Polysine-coated slides (Thermo Fisher). Antigen retrieval was achieved by heating at 98°C for 20 min in 1 mM Tris-HCl (pH 6.0). Immunofluorescence studies were performed on paraffin sections using antibodies against αSMA (Sigma-Aldrich; dilution 1/400), CALPONIN (TEBU; clone CP19, dilution 1/200) and HNK-1 (NeoMarkers; dilution 1/200). Nuclei were labelled with Hoescht (Invitrogen, France). After washing, slides were incubated 30 min with Alexa 488 anti-mouse (Invitrogen; 1:2000 dilution) and Alexa 555 anti-rabbit (Invitrogen; 1:2000 dilution). Cells were rinsed again, mounted in Fluorescent Mouting Medium (Dako, France). Immunohistochemistry control experiments were performed by excluding the primary antibody (data not shown).
Photography
Images were acquired using a Nikon Multizoom AZ100 stereomicroscope and a Carl Zeiss AxioImager microscope.
Results
Determination of gut mesenchyme initiated in the chick embryo at E4.5 in post-umbilical intestine
We first examined and compared the kinetics of vENCDCs migration and the differentiation of mesenchymal cells into SMCs by whole-mount in situ hybridization using SOX10 (marker of neural crest cells) and SM22 (marker of determined SMCs) probes on 4-day-old dissected GI tracts (E4 or Stage 23) (Fig. 1) . At this stage, SOX10 expression is detected in the vENCDCs that have colonized the developing lungs and stomach (Fig. 1a, b) . Posteriorly, SOX10 expression is observed in the sacral ENCCs (sENCCs) that form the ganglion of Remak (R) (Fig. 1a, c) . Conversely, SM22 transcripts were not detected at this stage in the whole GI tract (Fig. 1d-f) . However, its expression is detected in the umbilical vessel (uv) associated with the intestine (Fig. 1d, f) . Immunofluorescence analysis using both HNK-1 (marker of neural crest cells) and αSMA (marker of determined SMCs) antibodies indicated that at this stage, vENCDCs are randomly distributed in the mesenchyme of the developing stomach and duodenum (Fig. 1g , white arrowhead). No SMA-positive cells were detected in the GI tract (Fig. 1h) , indicating that the mesenchyme had not yet began to be determined at this stage. However, we observed αSMA-positive cells in the pharyngeal arches (pa) and in the allantois (al) (Fig. 1h) .
At E4.5 (Stage 24), SM22 transcripts are not detected in the stomach mesenchyme (Fig. 2d, e) . Interestingly, while the advancing wavefront of vENCDCs has reached the preumbilical intestine, as evidenced both by whole-mount in situ hybridization using SOX10 probe (Fig. 2a, b) and immunofluorescence analysis using HNK-1 antibodies (Fig. 2g ), a faint but detectable level of SM22 transcripts (Fig. 2f , arrowhead) Migrating vENCDCs are localized in the lung and the stomach and the GI mesenchyme is undifferentiated at E4. Scale bars 1 mm. Note SM22 expression in the umbilical vessel found around the small intestine. Immunofluorescence analyses performed on longitudinal paraffin sections using anti-HNK-1 (g) and anti-αSMA (h) antibodies. Scale bars 500 μm. al alantois; co colon; lg lung; R ganglion of Remak; pa pharyngeal arches; st stomach; uv umbilical vessel; vENCDCs vagal enteric neural crest-derived cells and αSMA protein (Fig. 2h, white arrowheads) was detected in the post-umbilical intestine, indicating that mesenchyme determination was initiated at this level of the GI tract.
Determination of stomach and colon mesenchyme observed in chick embryo at E5.5
At E5.5 (Stage 27), SM22 transcripts were detectable both in the stomach (Fig. 3d, e) , the colon and the rectum (Fig. 3d, f) , indicating that determination of stomach and colon mesenchyme occurs at similar stages in the chick embryo. SM22 expression was undetectable in the duodenum and the pylorus mesenchyme (Fig. 3d, e, white arrowhead) . In the small intestine, SM22 expression is faint in the ileum (il) and strong in the jejunum (je) (Fig. 3d, e) . Immunofluorescence analysis revealed αSMA immunoreactivity in the colon and rectum at this stage (Fig. 3i-l , white arrowheads) while the advancing wavefront of vENCDCs only reached the post-umbilical intestine, as evidenced both by SOX10-whole-mount in situ hybridization analysis (Fig. 3a, c) and immunofluorescence analysis for HNK-1 (Fig. 3g, h, k, l) . This observation indicates that determination of the mesenchyme in the colon is initiated while the colon is not yet populated by the vENCDCs. Immunofluorescence analysis performed on adjacent section using CALPONIN antibodies (a marker of differentiation) did not reveal CALPONIN immunoreactivity in the GI tract at this stage, indicating that determined mesenchyme had not yet began to be differentiated (data not shown).
Differentiation of stomach and colon mesenchyme observed in chick embryo at E6
At E6 (Stage 29), SM22 is expressed in the entire GI tract (Fig. 4d-f ) with the exception of the intermuscular tendon domain, found in the stomach and the pylorus (Fig. 4d , e, white Fig. 2 Post-umbilical intestine mesenchyme determination is initiated at E4.5 (stage 24). Whole-mount in situ hybridization analysis of SOX10 (a-c) and SM22 expression (d-f) using antisense riboprobes. b, e Magnified views of the stomach. c, f Magnified views of the colon. Mesenchyme determination is observed in the post-umbilical intestine area. Scale bars 1 mm. Note SM22 expression in the umbilical vessel that is present around the small intestine. Immunofluorescence analyses performed on longitudinal paraffin sections using anti-HNK-1 (g) and anti-αSMA (h) antibodies showing, respectively, the presence of vENCDCs in the duodenum and sENCCs in the ganglion of Remak (R). Note the presence of determined mesenchymal cells in the post-umbilical intestine (white arrowheads). White arrow indicates the unspecific HNK-1 staining in the mesenchyme of the ceca (g). Scale bars 500 μm. co colon; lg lung; R ganglion of Remak; st stomach; uv umbilical verssel; vENCDCs vagal enteric neural crest-derived cells arrowead), a posterior stomach structure while this domain is positive for SOX10 expression (Fig. 4b) . Immunofluorescence analysis revealed a strong αSMA and CALPONIN expression both in the stomach (Fig. 4g, h ) and the colon (Fig. 4i, j) . At this stage, the colon is not populated by the vENCDCs as demonstrated by SOX10-whole-mount in situ hybridization analysis (Fig. 4a, c) , showing the advancing wavefront of vENCCs at the level of the caecum and HNK-1 immunoreactivity (Fig. 4i, j, white arrowhead) . Indeed, at E7 (Stages 30-31), while the rectum is not yet colonized by the vENCDCs, as shown both by whole-mount in situ hybridization and immunofluorescence analysis (Fig. 5a, c, g ), it harbors a high level of expression of determined (SM22 and αSMA) and differentiated (CALPONIN) SMC markers (Fig. 5d, f, g, h) . We observed that Fig. 3 Colonic mesenchyme determination is initiated before vENCDCs colonization. Wholemount in situ hybridization analysis of SOX10 (a-c) and SM22 expression (d-f) using anti-sense riboprobes was performed at E5.5 (stage 27). b, e Magnified views of the stomach. c, f Magnified views of the colon. Mesenchyme determination is observed in the colon and small intestine sparing the duodenum area (d, e, white arrowhead). At this stage, the migrating vENCDCs have reached the ileum but did not enter into the colon. Scale bars 1 mm. Immunofluorescence analyses performed on longitudinal paraffin sections using anti-HNK-1 (g, h, k, l) and anti-αSMA (i-l) antibodies showing, respectively, the presence of vENCDCs in ileum but not in the colon structure, while determined mesenchymal cells are observed in the colon (j, l, white arrowheads). Note that, at this stage, HNK-1 staining was observed posteriorly in the ganglion of Remak (g, h, k, l, white arrows). Scale bars 200 μm. Aco colon; il ileum; je jejunum; R ganglion of Remak; st stomach; vENCDCs vagal enteric neural crest-derived cells the mesenchyme of the pylorus is still not determined at E7 (Stages 30-31) (Fig. 5e , white arrowhead). However, a faint level of SM22 staining in this structure was detected from E7.5 (Fig. S1 ).
Discussion
As they develop, each region of the GI tract acquires mesodermal and endodermal morphologies that can be easily discerned by gross and microscopic examination (Roberts 2000) . These tissues differentiate in a regionally specific pattern along the AP axis, designating the stomach, small intestines (duodenum, jejunum and ileum) and large intestines (colon and rectum). In addition to this AP axis patterning, the digestive mesenchyme differentiates and gives rise to the submucosa and smooth muscle layers. Patterning along the AP axis has been extensively examined and the importance of epithelio-mesenchymal interactions well established (Roberts et al. 1998; Roberts 2000; . However, digestive mesenchymal differentiation of the gut is poorly studied, while alterations of GI musculature have been observed in different digestive motility disorders such as chronic intestinal pseudoobstruction syndrome (Antonucci et al. 2008; Boeckxstaens et al. 2002; Notarnicola et al. 2012; Chetaille et al. 2014) . While recent studies have investigated some of the molecular mechanisms that control the differentiation of the mesenchyme of the stomach (for review, see Le Guen et al. 2015) , the examination of when mesenchyme differentiation occurs along the AP axis in the developing GI tract has not so far been reported.
Here, we report that determination of GI mesenchyme is initiated in the chick embryo at E4.5 at the level of the postumbilical intestine. At E5.5, determination of mesenchyme Fig. 4 Colonic mesenchyme differentiation is initiated before vENCDCs colonization. Wholemount in situ hybridization analysis of SOX10 (a-c) and SM22 expression (d-f) using anti-sense riboprobes was performed at E6 (stage 29). b, e Magnified views of the stomach. c, f Magnified views of the colon. Immunofluorescence analyses performed on longitudinal paraffin sections in the stomach (g, h) and the colon (i, j) using both anti-αSMA and anti- HNK-1 (g, i) or anti-CALPONIN antibodies (h, j) showing, respectively, the presence of vENCDCs in the ileum but not in the colon, while differentiated mesenchymal cells are found both in the stomach and colon. Note the expression of αSMA and CALPONIN in the blood vessel (i, j). Note that, at this stage, HNK-1 staining was observed posteriorly in the ganglion of Remak (i). Scale bars 200 μm. bv blood vessel; cae caecum; co colon; il ileum; R ganglion of Remak; st stomach; vENCDCs vagal enteric neural crest-derived cells was observed in the stomach and colon. We observed that the mesenchyme of the pylorus, a structure that connects the stomach to the duodenum (Moniot et al. 2004 ) and the duodenum were still not determined at E7. All together, these observations show that mesenchymal cells of the GI tract do not follow a global AP wave of differentiation in the chick embryo. These findings suggest regional-specific intrinsic or extrinsic mechanisms of mesenchyme differentiation along the AP axis in the GI tract. Developing pylorus and duodenum are two particular GI structures that undergo remodeling at these stages in order to give rise, respectively, to the pyloric sphincter and the connection with the pancreas (Roberts 2000; Grapin-Botton 2005) . These tissular events could explain why mesenchyme differentiation is not initiated at these levels. Moreover, the specific expression of different members of the WNT signaling pathway (TCF4 and SOX9) observed in the pyloric mesenchyme at E7 (Moniot et al. 2004; Theodosiou and Tabin 2003) could regulate mechanisms that inhibit mesenchyme differentiation.
We also examined in detail the kinetics of mesenchyme differentiation and vENCDCs migration. Our data show that, in the pre-umbilical part of the GI tract, mesenchyme differentiation in SMCs occurs after the vENCDCs colonization ; this study) and we previously showed that a critical number of vENCDCs is necessary for stomach mesenchyme differentiation . Interestingly, we report here that mesenchyme differentiation in SMCs in postumbilical intestine and colon starts in the absence of vENCDCs, suggesting that vENCDCs are not required for SMC differentiation in the post-umbilical part of the GI tract. During development, the post-umbilical mesenchyme, in addition to the vENCDCs, is also colonized by sENCCs that accumulated first in the ganglion of Remak of the mesorectum at E4.5 and then penetrate into the gut wall through dorsoventral migration at E7.5 (Pomeranz and Gershon 1990; Burns and Le Douarin 1998) . Our data clearly show that mesenchyme differentiation in SMCs is initiated in the postumbilical intestine and colon well before penetration of the sENCCs into the mesenchyme. These observations suggest that vENCDCs are not required for SMC differentiation in the post-umbilical part of the GI tract, although we cannot rule out the influence of diffusible signals from sENCCs located in Fig. 5 Differentiation of GI smooth muscle at E7. Wholemount in situ hybridization analysis of SOX10 (a-c) and SM22 expression (d-f) was performed at E7 (Stages 30-31) using antisense riboprobes. b, e Magnified views of the stomach. c, f Magnified views of the colon. Smooth muscle in the whole GI tract sparing the duodenum and pylorus areas (arrowhead in e). Migrating vENCDCs have reached the middle of the colon. Scale bars 1 mm. Immunofluorescence analyses performed on longitudinal paraffin sections on the colon using both anti-αSMA and anti-HNK-1 (g) or anti-CALPONIN (h) antibodies showing respectively the wavefront of vENCDCs migration at the level of the mid-colon while digestive SMCs are detected in the colon. Note that, at this stage, HNK-1 staining was observed posteriorly in the ganlion of Remak (g). Scale bars 200 μm. ap anal plate; co colon; R ganglion of Remak; re rectum; st stomach; vENCDCs vagal enteric neural crest-derived cells the ganglion of Remak that could participate in the determination of post-umbilical mesenchyme into SMCs. In addition, we observed that the umbilical vessel is associated with the developing intestine as soon as E4, close to the site of SMC determination in the post-umbilical intestine. Thus, it could influence the determination of the post-umbilical mesenchyme into SMCs.
When colonizing the stomach and the intestine, the migration front of vENCC is located in the outermost layer of the mesenchyme, adjacent to the serosal epithelium and will migrate inwards to set up plexuses (Tucker et al. 1984; Burns and Le Douarin 1998) . In contrast, in the colorectum area, vENCDCs initially colonize the submucosal layer before migrating outwards to organize the myenteric plexus (Burns and Le Douarin 1998) . Our data clearly show that, in the stomach, vENCDCs migrate through developing mesenchyme, while, in the colon, they migrate through differentiated smooth muscle. These results could in part explain the difference of colonization of vENCDCs into the colorectum compared to the other part of the GI tract. Moreover, it has been reported that interactions between vENCDCs and mesenchyme/muscle are critical for vENCDCs migration (Hao et al. 2016; Heanue et al. 2016) . The digestive mesenchyme secretes neurotrophic factors whose receptors are located on the vENCDCs. Mesenchymal cells may express different repertoires of neurotrophic factors and extracellular matrix proteins depending on their status of differentiation (Hao et al. 2016; Breau et al. 2006; Raghavan and Bitar 2014) . The status of mesenchyme differentiation could be critical for the development and migration of vENCDCs in the colon. In line with this hypothesis, we previously showed by using an avian-specific retroviral misexpression system that deregulation of BMP signaling within the mesenchyme of the colon impairs its differentiation into SMC and therefore induces abnormal vENCDCs development (de Santa Barbara et al. 2005) . Our data point to the interest of further studies to identify specific pathways and factors that could be involved in the colonic SMC differentiation process.
